Dov A Md Goldstein Bio Age Labs, Inc. (BIOA) insider trading activity

BIOA Quotes by TradingView
Shares Held (Direct Ownership) 22.4K
n/a 3M change
n/a 12M change
Total Value Held N/A

DOV A MD GOLDSTEIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 13 2026
SELL
Open market or private sale
$536,760 $19.88 p/Share
27,000 Reduced 54.65%
22,408 Common Stock
Jan 13 2026
BUY
Exercise of conversion of derivative security
$226,530 $8.39 p/Share
27,000 Added 35.34%
49,408 Common Stock

Also insider at

NBSE
NeuBase Therapeutics, Inc. Healthcare
Director
GANX
Gain Therapeutics, Inc. Healthcare
Director
COYA
Coya Therapeutics, Inc.
DAM

Dov A Md Goldstein

Chief Financial Officer
Pittsburgh, PA

Track Institutional and Insider Activities on BIOA

Follow BioAge Labs, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIOA shares.

Notify only if

Insider Trading

Get notified when an Bio Age Labs, Inc. insider buys or sells BIOA shares.

Notify only if

News

Receive news related to BioAge Labs, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BIOA